医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Hoya Announces Second Quarter Financial Results

2014年10月30日 PM07:13
このエントリーをはてなブックマークに追加


 

TOKYO

Hoya Corporation (TOKYO: 7741) today announced financial results for the second quarter ended September 30, 2014.

During the quarter, revenues totaled 121,242 million yen, increasing by 18.6% from the same period the previous year. Pre-tax profit for the quarter was 34,256 million yen, while profit for this quarter was 27,323 million yen, both of which marked gains of 114.5% and 113.9%, respectively. Profit attributable to owners of the company stood at 27,150 million yen, an increase of 113.3% compared to the same quarter in the previous year.

During the quarter, sales of products for smartphones and tablet PCs as well as sales of glass disks for HDDs performed well in the Information Technology segment, but sales of digital camera related products continued to perform weakly. Meanwhile in the Life Care segment, we significantly increased sales in the eyeglass lens business in overseas markets and through inclusion of Seiko Optical Products, a sales company of SEIKO eye wear, as a consolidated subsidiary. The retail contact lens business in Japan experienced last-minute demand up until March and a downward reversal beginning in April due to the April 1 hike in the consumption tax rate, thus resulting a year-on-year drop in earnings. The endoscope business performed robustly primarily in Asia.

For the six months ended September 30, 2014, revenues totaled 234,314 million yen, and pre-tax profit was 56,700 million yen, both of which increased 15.6% and 57.1% respectively. Profit for the term increased 80.4% to 45,285 million yen, and profit attributable to owners of the company was up 79.6% to 44,948 million yen compared to the same quarter in the previous year.

“The profit for this quarter exceeded our expectation due primarily to solid result of the Information Technology segment,” said Hiroshi Suzuki, chief executive officer of HOYA. “We see that this trend will persist for a while.”

“This quarter our measures of swift restructuring in the Information Technology segment bore fruit,” commented Eiichiro Ikeda, chief operating officer, Information Technology. “We will drive growth in areas where there are opportunities amid overall shrinking markets.”

HOYA also announced the interim dividends of 30 yen per share of common stock.

 

Summary of Consolidated Financial Statement

(Millions of Yen: Rounded to the nearest million)
      Three months ended   Variance   Six months ended   Variance
      9/13   9/14   (%) 9/13   9/14   (%)
Revenue 102,236   121,242 18.6 202,661   234,314 15.6
Profit before tax 15,972 34,256 114.5 36,095 56,700 57.1
Profit for the term 12,773 27,323 113.9 25,107 45,285 80.4
Profit attributable to owners of the company 12,729 27,150 113.3 25,030 44,948 79.6
Basic earnings per share(yen)   29.50   64.12     58.00   105.30  

*Results are preliminary and unaudited.

 

The full reports are available at: www.hoya.com

About HOYA

Founded in 1941 in Japan, Hoya is a global med-tech company and a leading supplier of innovative high-tech and medical products. Hoya is active in the fields of Life Care and Information Technology providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses as well as key components for semiconductor devices, LCD panels and HDDs. Hoya currently employs over 35,000 people worldwide. For more information, please visit http://www.hoya.com.

CONTACT

HOYA Corporation
Akiko Chiba, +81-3-3952-6416
Public Relations
akiko.chiba@hoya.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表